Nature (almost) always prevails - challenging the status quo of artificial cycle frozen embryo transfers.

Artificial cycle Assisted reproductive technologies Frozen embryo transfer Natural cycle Natural proliferative phase

Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 17 07 2023
revised: 15 08 2023
accepted: 15 08 2023
pubmed: 8 10 2023
medline: 8 10 2023
entrez: 7 10 2023
Statut: ppublish

Résumé

Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the 'freeze-all' strategy. The choice between artificial or natural cycles for FET preparation has been a subject of debate, considering factors such as endometrial receptivity, flexibility of scheduling and pregnancy outcomes. While artificial cycle protocols offer convenience and flexibility, studies have suggested potential drawbacks, including higher miscarriage rates and a greater risk of hypertensive disorders during pregnancy. In contrast, natural cycle protocols involve a frequently demanding monitoring of both endometrial proliferation and follicular growth, which may lead to increased clinic visits and scheduling issues. Multiple strategies have been proposed to enhance the usage of natural cycle FET, including addressing anovulation through minimal stimulation, reducing cycle monitoring and exploring novel FET approaches. These novel approaches, such as widening the window for human chorionic gonadotrophin administration and the natural proliferative phase protocol, offer promising outcomes and increased convenience for patients. However, further research is needed to establish the optimal timing and effectiveness of these strategies. Overall, enhancing the practicality of natural cycle FETs is crucial for expanding their utilization during ART.

Identifiants

pubmed: 37804605
pii: S1472-6483(23)00452-2
doi: 10.1016/j.rbmo.2023.103352
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103352

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Samuel Santos-Ribeiro (S)

IVIRMA Global Research Alliance, IVIRMA Lisboa, Lisbon, Portugal.; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.. Electronic address: samuel.ribeiro@ivirma.com.

Catarina M Godinho (CM)

IVIRMA Global Research Alliance, IVIRMA Lisboa, Lisbon, Portugal.

Sérgio Reis-Soares (S)

IVIRMA Global Research Alliance, IVIRMA Lisboa, Lisbon, Portugal.

Classifications MeSH